Below are 13 healthcare venture capital deals announced in the past month.
1. Vicarious Surgical, a Cambridge, Mass.-based developer of virtual reality software for minimally invasive surgery procedures, completed a $10 million funding round led by Bill Gates’ Gates Frontier.
2. Vor Biopharma, a Boston-based stem cell therapy startup focused on the treatment of hematological malignancies, completed a $42 million Series A financing round led by 5AM Ventures and RA Capital Management.
3. Phylagen, a San Francisco-based data analytics company building an environmental microbiome database, raised $14 million in Series A funding from Cultivan Sandbox, Breakout Ventures and Working Capital.
4. Nuvaira, a Minneapolis-based developer of therapeutic medical devices to treat obstructive lung disease, closed a $79 million equity financing led by U.S. Venture Partners.
5. Culture Biosciences, a South San Francisco-based biotechnology company, raised $5.5 million in a funding round led by Section 32.
6. KenSci, a Seattle-based risk prediction platform for healthcare, closed $22 million in Series B funding. Polaris Partners led the funding round.
7. Health Catalyst, a Salt Lake City-based data and analytics company, raised $100 million in Series F equity and debt funding. OrbiMed led the funding round.
8. HiberCell, a New York City-based biotechnology company, raised $60.75 million in Series A funding. Arch Venture Partners led the funding round.
9. Day Zero Diagnostics, a Boston-based infectious disease diagnostic company, completed an $8.6 million Series A funding round led by Triventures.
10. Clover Health, a San Francisco-based health insurance startup, completed a $500 million funding round led by Greenoaks Capital Management.
11. Dewpoint Therapeutics, a Cambridge, Mass.-based drug discovery startup, completed a $60 million Series A funding round led by Polaris Partners.
12. Phynd Technologies, a Dallas-based information management platform, completed an $8 million Series B funding round. Participating investors included MemorialCare Innovation Fund, Rex Ventures, Orlando Healthcare Ventures and Dallas Venture Partners.
13. Lyndra Therapeutics, a Watertown, Mass.-based biotechnology startup, raised $55 million in Series B financing. Polaris Partners led the funding round.
More articles on healthcare finance:
Investment losses hit Duke University Health System’s bottom line
Arkansas hospital’s power temporarily shut off due to nonpayment
Wake Forest Baptist sees operating income sink 54% in Q2
